Shi-Ting Jiang

557 total citations
8 papers, 462 citations indexed

About

Shi-Ting Jiang is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, Shi-Ting Jiang has authored 8 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Pharmacology. Recurrent topics in Shi-Ting Jiang's work include Estrogen and related hormone effects (4 papers), Pharmacological Effects of Natural Compounds (2 papers) and Medicinal Plant Pharmacodynamics Research (2 papers). Shi-Ting Jiang is often cited by papers focused on Estrogen and related hormone effects (4 papers), Pharmacological Effects of Natural Compounds (2 papers) and Medicinal Plant Pharmacodynamics Research (2 papers). Shi-Ting Jiang collaborates with scholars based in China, United States and Taiwan. Shi-Ting Jiang's co-authors include V. Craig Jordan, Marco M. Gottardis, Meei Huey Jeng, Steve R. Roffler, M Y Yeh, Tsu‐Chung Chang, Chengxia Li, Wenli Yang, Xiaofang Jia and Chao Tang and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Molecules and European Journal of Cancer.

In The Last Decade

Shi-Ting Jiang

7 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shi-Ting Jiang China 4 372 240 171 73 58 8 462
Lianguo Kang United States 6 328 0.9× 250 1.0× 207 1.2× 56 0.8× 67 1.2× 7 521
V C Jordan United States 9 394 1.1× 180 0.8× 163 1.0× 90 1.2× 56 1.0× 11 476
A. E. Lykkesfeldt Denmark 7 228 0.6× 209 0.9× 186 1.1× 76 1.0× 70 1.2× 10 415
Joan S. Lewis United States 9 400 1.1× 338 1.4× 243 1.4× 124 1.7× 55 0.9× 9 683
Sandra Timm Pearce United States 7 296 0.8× 253 1.1× 116 0.7× 63 0.9× 26 0.4× 7 518
Helen R. Kim United States 9 199 0.5× 213 0.9× 162 0.9× 85 1.2× 43 0.7× 9 420
V. Craig Jordan United States 9 392 1.1× 156 0.7× 184 1.1× 121 1.7× 103 1.8× 9 502
Jennifer MacGregor Schafer United States 9 296 0.8× 231 1.0× 155 0.9× 105 1.4× 28 0.5× 10 451
R. C. Dardes Brazil 10 279 0.8× 126 0.5× 135 0.8× 65 0.9× 30 0.5× 17 391
Mary D. Adrian United States 12 351 0.9× 166 0.7× 109 0.6× 50 0.7× 100 1.7× 18 613

Countries citing papers authored by Shi-Ting Jiang

Since Specialization
Citations

This map shows the geographic impact of Shi-Ting Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi-Ting Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi-Ting Jiang more than expected).

Fields of papers citing papers by Shi-Ting Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi-Ting Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi-Ting Jiang. The network helps show where Shi-Ting Jiang may publish in the future.

Co-authorship network of co-authors of Shi-Ting Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Shi-Ting Jiang. A scholar is included among the top collaborators of Shi-Ting Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi-Ting Jiang. Shi-Ting Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Jiang, Shi-Ting, Chengxia Li, Dan Liu, et al.. (2025). Role, mechanisms and effects of Radix Bupleuri in anti‑breast cancer (Review). Oncology Letters. 29(4). 166–166. 1 indexed citations
2.
Li, Chengxia, et al.. (2025). Anticancer effects of salvianolic acid A through multiple signaling pathways (Review). Molecular Medicine Reports. 32(1). 1–11.
3.
Tang, Chao, Shi-Ting Jiang, Chengxia Li, Xiaofang Jia, & Wenli Yang. (2024). The Effect of Salvianolic Acid A on Tumor-Associated Macrophage Polarization and Its Mechanisms in the Tumor Microenvironment of Triple-Negative Breast Cancer. Molecules. 29(7). 1469–1469. 4 indexed citations
4.
Jiang, Shi-Ting, et al.. (1996). Tamoxifen inhibits hepatoma cell growth through an estrogen receptor independent mechanism. European Journal of Gastroenterology & Hepatology. 8(4). 410–410. 1 indexed citations
5.
Jiang, Shi-Ting, et al.. (1995). Growth regulation by all-trans-retinoic acid and retinoic acid receptor messenger ribonucleic acids expression in gastric cancer cells. European Journal of Cancer. 31(2). 237–243. 22 indexed citations
6.
Jiang, Shi-Ting & V. Craig Jordan. (1992). Growth Regulation of Estrogen Receptor-Negative Breast Cancer Cells Transfected With Complementary DNAs for Estrogen Receptor. JNCI Journal of the National Cancer Institute. 84(8). 580–591. 222 indexed citations
7.
Jiang, Shi-Ting & V. Craig Jordan. (1992). A molecular strategy to control tamoxifen resistant breast cancer.. PubMed. 14. 55–70. 3 indexed citations
8.
Gottardis, Marco M., et al.. (1989). Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.. PubMed. 49(15). 4090–3. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026